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Abstract
Background:Methicillin-resistant Staphylococcus aureus (MRSA) have emerged as an
important cause of nosocomial and community-acquired infections ranging frommild
to severe life-threatening infections. Therefore, a reliable detection of such strains is
required for effective treatment.
Objectives: To determine the frequency and the antibiogram of MRSA among
different clinical isolates.
Study Design: A cross-sectional, descriptive study.
Materials and Methods: Standard bacteriological methods, disk diffusion and PCR
were performed to determine the frequency of MRSA among different clinical
isolates.
Results: The overall results showed 96/210 (45.7%) of isolates were MRSA mostly
recovered fromwounds and blood stream. High percentage was detected in hospital-
associated (HA) strains (64.2%) rather than community (CA) (37.1%) (P-value
< 0.001). From the generated Antibiogram, Co-trimoxazole was the most active
(80.2%), while Penicillin was the least one (6.2%).
Conclusion: AsMRSA strains were mostly isolated from Hospitals, clinicians should be
aware of such burden strains. Local frequency investigation ofMRSA is recommended
for perfect diagnosis and treatment.
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1. Introduction
The Staphylococcus aureus has been recognized as one of the major human pathogens.
It has been reported as the cause of spectrum of infections in hospitals and throughout
the communities [1]. Humans and animals are the natural reservoirs of S. aureus. It has
been reported that from 10 to 40% of people not associated with hospitals are carriers
of S. aureus and the predominant sites of its colonization were the throat and anterior
nares [2]. It is considered as one of the most common causes of soft tissues and skin
infections such as carbuncles, abscesses, furuncles, folliculitis, impetigo, cellulitis, and
bullous impetigo [3]. Other than skin and soft tissue infections, S. aureus is known to
cause bone and joint infections, pneumonia, endocarditis, and scalded skin syndrome
[4]. Methicillin-resistant S. aureus (MRSA) was first reported from the United Kingdom
(UK) in 1961 [5]. In the following decades, MRSA had been established as amajor noso-
comial pathogen worldwide with a significant economic impact on healthcare systems
[6]. Several reports indicated that MRSA infections have been associated with high
mortality, morbidity, and high treatment cost. Furthermore, failure to identify MRSA in
patients results in therapy failure and thus increases overall morbidity and mortality as
well as the cost effectiveness [7–9]. MRSA resistance to methicillin has been attributed
to a number of mechanisms, but the chief factor is supposed to be its ability to pro-
duce specific penicillin-binding protein 2a (PBP-2a) that renders β-lactamase-resistant
penicillin ineffective including all other β-lactam drugs [10]. The PBP-2a has shown a
usual low binding affinity for almost all beta-lactam antibiotics as compared to native
PBPs [11]. The PBP-2a is coded and induced by themecA gene, a part of Staphylococcal
cassette chromosome (SCCmec). The SCCmec is known to be present in MRSA but not
in the methicillin-susceptible S. aureus (MSSA) strains [12–14]. According to their origin,
MRSA strains were classified into two main types: community-associated MRSA (CA-
MRSA) and hospital-associated MRSA (HA-MRSA). However; the prevalence varies
from country to country, where most MRSA strains have been hospital-associated
(HA-MRSA) [15, 16]. For most countries affected by MRSA, there have been many
years of debate about its relative virulence compared with methicillin-susceptible S.
aureus (MSSA) and whether it could be controlled. MRSA is endemic in the majority
of hospitals around the world, and it is now considered as an additional burden of
healthcare-acquired infection [8]. In the current study, the presence of mecA gene
was investigated in S. aureus strains isolated from three Khartoum major hospitals.
This cross-sectional study was designed to determine the frequency of MRSA strains
and to elucidate their distribution among community and hospital strains.
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2. Methods
The current study was performed mainly in Khartoum state; during the period from
2013 to 2015. The specimens were collected from three Khartoum major hospitals –
Khartoum teaching hospital, Alribat teaching hospital, and the Military hospital. Study
subjects were patients presented with any S. aureus-suspected infections. Scientific
and ethical approval of the study was obtained from the ethical committee of Tropical
Medicine Research Institute (Sudan).
2.1. Bacterial identification
The isolation and identification of bacterial isolates was done as described previously
by Cowan et al. (1993) [17] and Collee et al. (1996) [18]. Two hundred and ten S. aureus
isolates were recovered from different sites of infections. S. aureus ATCC 25923 was
used as control strain in all procedures.
2.1.1. Criteria for labeling isolates as community associated (CA) or
hospital associated (HA)
The isolates were differentiated into community or hospital strains according to the
CDC standardized definition [19].
2.2. Antibiotic susceptibility testing
Muller-Hinton agar was used to test the isolates to different antibiotics according to
CLSI, (2006) [20].
2.2.1. Testing isolates for methicillin resistance
Standard disk diffusion was done using oxacillin 1μg to differentiate MRSA from MSSA
strains. A zone size of ≥ 10 mm was considered resistant; a zone size of ≥13 mm was
considered susceptible [20].
2.3. Molecular detection of mecA gene
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2.3.1. DNA extraction
DNA extraction was performed using DNeasy kit (QIAGEN). Pretreatment of bacterial
cells was done according to the manufacturer instructions.
2.3.2. PCR amplification
mecA specific primers were used (Metabion International-Germany) as follows:mecA-
1 (5 -AAA ATC GAT GGT AAA GGT TGG C- 3), mecA-2 (5 -AGT TCT GCA GTA CCG GAT
TTG C- 3) for detection of the methicillin-resistant gene. Single PCR amplifications
were performed in 25 µl reaction mixture (Maxime PCR PreMix Kit i-Taq 5 µl) (INTRON
Biotechnology, South Korea), containing 3µl of bacterial DNA template, 1 µl of 5 pmol/µl
from each primers, and themixturewas completedwith 15 µl of sterile distilledwater in
a 0.2 Eppendorf (PCR) tube. Amplifications were performed by using the thermalcycler
as follows:
An initial denaturing step at 94ºC for 3 min followed by 30 cycles of amplification
with 94ºC for 30 S, annealing at 55ºC for 30 S, and extension at 72ºC for 30 S, except
for the final cycle which had an extension step of 4 min. The size of the PCR product
was 532 bp [21].
3. Results
3.1. Oxacillin disk diffusion result
80/210 (38.1%) of the S. aureus isolates were found to be MRSA while the remainder
130 (61.9%) were found to be MSSA.
3.2. PCR result
It is observed that 96/210 (45.7%) of isolates were mecA positive (MRSA), while 114
(54.3%) were mecA negative (MSSA) (Figure 1).
3.3. Distribution of MRSA according to the site of infection
According to the anatomical site of infection, the distribution of the encountered MRSA
isolates was as follows: Surgical wound infection 40 (63.5%), skin and soft tissues 15
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(34.1), paronychia 10 (37.0%), bone 8 (44.4%), urinary tract 5 (45.5%), ear infection 3
(37.5%), blood stream 5, others 7 (53.8%) (Table 1).
3.4. Frequency of MRSA according to the source
Among the total isolated community strains (143), themecA positive (CA-MRSA) were
53 (37.1%), while among the total isolated hospital strains (67), themecA positive (HA-
MRSA) were 43 (64.2%) with significant difference (P-value < 0.001) (Table 2).
3.5. Antibiotics sensitivity pattern of MRSA isolates
With regard to MRSA isolates, we found that the most active antibiotic was Co-
trimoxazole (80.2%), while the Penicillin was the least active (6.2%) (Table 3).
 
Figure 1: Number and percentage of detected MRSA and MSSA strains by disk diffusion and PCR (mecA
detection).
4. Discussion
In the last few years MRSA have emerged as one of important medical pathogens.
Hence, their rapid and accurate detection is of vital importance to formulate strate-
gic interventions such as effective treatment regimens and sound control measures
to combat and hinder their spread. However, the present study demonstrated that
encountered MRSA strains are less frequent than MSSA while using standard disk
diffusion and PCR procedures. This may be attributed to the more frequent MSSA
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Figure 2: Detection ofmecA gene by PCR in 1.5% agarose gel electrophoresis. M: 100 bp molecular ladder;
lane (1 & 13): positive control; lane 2: isolate 131; lane 3: isolate 174; lane 4: isolate 175; lane 5: isolate 176;
lane 6: isolate 177; lane 7: isolate 178; lane 8: isolate 179; lane 9: isolate 180; lane 10: isolate 181; lane 11:
182; lane 12: negative control. (Isolates 131, 175, 176, 177, 180, and 182 were mecA gene positive (MRSA)
with product size 532 bp, while isolates 174, 178, 179 and 181 were mecA gene negative MSSA.)
T 1: Distribution of isolated MRSA and MSSA strains according to the site of infection.
Site of Infection Number (n) MRSA (%) MSSA (%)
Surgical wound 63 40 (63.5) 23 (36.5)
Skin and soft tissues 44 15 (34.1) 29 (65.9)
Paronychia 27 10 (37.0) 17 (63.0)
Bone 18 8 (44.4) 10 (55.6)
Urinary tract 11 5 (45.5) 6 (54.5)
Ear 8 3 (37.5) 5 (62.5)
∗Aspiration 7 0 7 (100)
Blood stream 7 5 (71.4) 2 (28.6%)
Throat 5 3 (60.0) 2 (40.0%)
Nasal cavity 5 0 5 (100)
Respiratory tract 2 0 2 (100)
∗∗Others 13 7 (53.8) 6 (46.2)
Total 210 96 114
Notes: ∗Aspiration include: Peritoneal (3), Pleural (2), Knee (2); **others include:
tracheal swab (3), breast infection (2), umbilical swab (2), uterus swab (1), tissue
biopsy (1), vaginal discharge (1), myositis (1), bacteremia (1) and semen (1).
T 2: Frequency of MRSA and MSSA community (CA) and hospital (HA) strains.
Type of Isolate CA–S. aureus (n = 143) HA- S. aureus (n = 67) ∗P-value
MRSA 53 (37.1%) 43 (64.2%) < 0.001
MSSA 90 (62.9%) 24 (35.8%) —
Notes: *p-value calculated using chi-square test; CA = community associated; HA=
hospital associated.
strains rather than MRSA. Similar results were reported by different previous studies
as that of Butt et al. (2004) and Durmaz et al. (1997) [22, 23]. Our finding showed that
16 isolates of the 130 MSSA isolates were phenotypically susceptible when tested by
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T 3: Antibiogram of some antibiotics used against MRSA isolates (total number 96 isolates).







Co-trimoxazole 77 (80.2%) 18 (18.8%) 1 (1%)
Ciprofloxacin 44 (45.9%) 23 (23.9%) 29 (30.2%)
Gentamicin 39 (40.6%) 49 (51.1%) 8 (8.3%)
Cefazolin 33 (34.4%) 50 (52.1%) 13 (13.5%)
∗Amoxiclav 22 (22.9%) 74 (77.1%) –
Penicillin G 3 (3.1%) 93 (96.9%) –
Note: ∗Amoxiclav = amoxicillin clavulanic acid.
oxacillin disk diffusion, but when subjected to PCR they were found to be mecA gene
positive. The remaining 80 isolates were detected as MRSA by both disk diffusion
and PCR. No one of the phenotypically resistant isolates was found to be negative by
PCR. However, the molecular assays now considered as standard method for genes
detection including mecA gene and for discrimination of S. aureus from other species
through multiplex PCR [24]. Even the PCR technique is used now as gold standard
technique to evaluate the other conventional methods as done by Perez et al. [11].
Moreover, HA-MRSA (64.2%) were detected in a higher rate than the CA-MRSA strains
significantly (P-value < 0.001) which supported our general impression. This finding
was in consistence with that of Huang et al. (2006) who reported that MRSA strains
were detected more frequently (55.1%) in hospital isolates [25]. On the other hand,
the detected number of CA-MRSA strains may support the possibility that CA-MRS
infections are in increase as observed in some other countries [19 26]. Furthermore,
in the present investigation, MRSA infections were found to be distributed in dif-
ferent anatomical positions (Table 2). This may explain the increasing incidence of
MRSA infections, which may be reflected by the increased duration of hospitalization
and therefore increase in the overall treatment expenditure as stated by Cosgrove
et al. [27]. With regard to antibiotics-susceptibility profile of MRSA, co-trimoxazole
was found to be the most effective one (80.2%), followed by vancomycin (47%),
ciprofloxacin (45.8%), and gentamicin (40.6%). These results explain why the co-
trimoxazole was considered as one of the drugs used to treat MRSA infections [28–
31]. For ciprofloxacin and gentamicin, the generated results are comparable to those
reported in India where less than 30% were found to be resistant to ciprofloxacin,
while about 40–50% were found to be resistant to gentamicin [32]. The susceptibility
of MRSA isolates to β-lactam antibiotics was found to be 34.4%, 22.9%, and 3.1% for
cefazolin, amoxicillin clavulanic acid, and penicillin, respectively. The high resistance
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may be due to the production of additional β-lactamase by MRSA strains rendering
them to resist improved antibiotics such as cefazolin and amoxicillin clavulanic acid.
Schweizer et al. (2011) stated that cefazolin does not work in case of MRSA [33]. The
current study had certain limitations. First, the study was done in only three major
hospitals in the study area. Second, some sites of infection which can be infected by
S. aureuswere not represented here. In conclusion, this study reported significant high
frequency of MRSA in hospital isolates. Moreover, these strains were mostly isolated
from surgical wounds and blood stream. It is recommended that clinicians should be
aware of themost active antibiotics against MRSA such as co-trimoxazole, vancomycin
and ciprofloxacin.
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